LCOV
London Company of Virginia’s Haemonetics HAE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.4M | Buy |
286,515
+10,695
| +4% | +$798K | 0.12% | 100 |
|
|
2025
Q1 | $17.5M | Sell |
275,820
-5,918
| -2% | -$376K | 0.1% | 108 |
|
|
2024
Q4 | $22M | Buy |
281,738
+6,111
| +2% | +$477K | 0.12% | 106 |
|
|
2024
Q3 | $22.2M | Sell |
275,627
-9,873
| -3% | -$794K | 0.12% | 103 |
|
|
2024
Q2 | $23.6M | Buy |
285,500
+106,409
| +59% | +$8.8M | 0.13% | 98 |
|
|
2024
Q1 | $15.3M | Buy |
179,091
+21,579
| +14% | +$1.84M | 0.08% | 110 |
|
|
2023
Q4 | $13.5M | Sell |
157,512
-18
| -0% | -$1.54K | 0.08% | 113 |
|
|
2023
Q3 | $14.1M | Buy |
157,530
+1,710
| +1% | +$153K | 0.08% | 102 |
|
|
2023
Q2 | $13.3M | Buy |
155,820
+984
| +0.6% | +$83.8K | 0.08% | 105 |
|
|
2023
Q1 | $12.8M | Sell |
154,836
-505
| -0.3% | -$41.8K | 0.07% | 104 |
|
|
2022
Q4 | $12.2M | Sell |
155,341
-6,529
| -4% | -$514K | 0.07% | 107 |
|
|
2022
Q3 | $12M | Sell |
161,870
-991
| -0.6% | -$73.4K | 0.08% | 105 |
|
|
2022
Q2 | $10.6M | Sell |
162,861
-808,150
| -83% | -$52.7M | 0.06% | 112 |
|
|
2022
Q1 | $61.4M | Buy |
971,011
+53,653
| +6% | +$3.39M | 0.32% | 71 |
|
|
2021
Q4 | $48.7M | Sell |
917,358
-100,055
| -10% | -$5.31M | 0.25% | 75 |
|
|
2021
Q3 | $71.8M | Sell |
1,017,413
-35,570
| -3% | -$2.51M | 0.39% | 66 |
|
|
2021
Q2 | $70.2M | Sell |
1,052,983
-4,755
| -0.4% | -$317K | 0.37% | 70 |
|
|
2021
Q1 | $117M | Buy |
1,057,738
+117,522
| +12% | +$13M | 0.67% | 53 |
|
|
2020
Q4 | $112M | Buy |
+940,216
| New | +$112M | 0.7% | 58 |
|